ABSTRACT The role of histamine HI and H2 receptors in the lung is not clear. HI receptor blockade results in bronchodilatation and inhibition of histamine induced bronchoconstriction. H2 receptor blockade in vitro prevents the normal negative feedback of histamine on further mediator release in antigen challenge. Bronchospasm in guinea pigs given antigen challenge is enhanced by previous administration of metiamide or burimamide but not of cimetidine. These findings suggest the possible deleterious effect of H2 receptor antagonists in asthmatic subjects. The effects of H2 receptor blockade with cimetidine on bronchial hyperreactivity to histamine were studied in 10 asthmatic volunteers by whole body plethysmography. Cimetidine 800 mg and placebo were administered orally on two separate days, eight hours and two hours before study. No significant difference in baseline levels of airways obstruction was seen with the two agents. Inhalational challenge with increasing concentrations of histamine revealed no significant difference in bronchial hyperreactivity to histamine between cimetidine and placebo treatment days. H2 receptor blockade with cimetidine does not appear to affect ventilatory function or bronchial hyperreactivity to histamine in asthmatic subjects. It has been suggested that cimetidine may have HI as well as H2 receptor blocking properties which prevent this effect.
The role of histamine in the pathogenesis of bronchial asthma remains controversial. Histamine is released from the lungs of asthmatic patients both in vitro' and in vivo2 on appropriate allergen challenge while raised plasma histamine levels are found in spontaneously occurring asthmatic attacks.3 4 Bronchial hyperreactivity to inhaled histamine5 is prevented by HI receptor blocking agents given parenterally6 and by inhalation. 8 While orally administered HI blockers are clinically ineffective in asthma, when given by inhalation, such agents are potent bronchodilators. 9 These findings suggest that histamine acting on HI receptors in the bronchi is important in the pathogenesis of the asthmatic attack.
The importance of the H2 receptor is less clear. Histamine added to leucocyte preparations has been shown to inhibit mediator release induced by antigen exposure. 10 This effect is abolished by previous administration of the H2 fig 1) . 9 The mean percentage fall in sGaw for each histamine concentration was obtained for cimetidine and placebo treatment days. No significant differences were found between the effect of the two treatments at any histamine concentration. Thus the administration of cimetidine did not prevent or enhance histamine-induced bronchoconstriction in these subjects.
Discussion
In vitro studies suggest that the H2 receptor has a role in the modulation of mechanisms involved in asthmatic attacks. Exogenous histamine has been shown to inhibit the release of histamine from leucocytes and this effect is blocked by H2 receptor blockade with burimamide and metiamide. 12 The effect is thus thought to be the result of H2 receptor stimulation and is associated with a rise in cyclic adenosine monophosphate.10 Such a use is also seen when a specific H2 receptor agonist, demaprit, is given.'8 H2 receptor blockade with metiamide has been shown to potentiate histamine release induced by anti IgE in monkeys previously sensitised to IgE. 19 The H2 receptor may also have a role in modulating the effect of histamine on bronchial smooth muscle. Hi receptor blockade leads to histamine-induced bronchodilatation which is abolished by metiamide. 13 H2 receptor blockade might be expected to lead therefore to enhanced mediator release and unopposed HI receptor-induced smooth muscle contraction. Earlier in vivo studies have failed to show this effect. Asthmatic subjects given cimetidine and placebo in a four-week crossover study showed no change in clinical state determined by daily peak flow measurements and symptom scores. There was no change in the severity of exercise-induced asthma in these patients when given cimetidine.
Inhaled histamine causes bronchoconstriction by a direct effect on bronchial smooth muscle and mucosa, and by stimulation of irritant receptors leading to vagally mediated reflex bronchoconstriction. 20 21 From the in vitro results it seems likely that the effect of inhaled histamine might be modulated by H2 receptor stimulation leading to inhibition of endogenous mediator release and to bronchodilatation produced by H2 receptor stimulation in bronchial smooth muscle. Our study, however, also failed to demonstrate any such H2 receptor effect. Cimetidine-induced H2 receptor blockade did not cause any increase in resting levels of airways obstruction or increase bronchial hyperreactivity to histamine. This discrepancy between in vitro studies with metiamide and burimamide, and in vivo studies
Stephen G Nogrady and Carol Bevan with cimetidine could simply be the result of dosage and route of administration. HI receptor antagonists given by inhalation9 or in large parenteral dosages22 have broncholidator properties which are not evident when given orally in conventional doses. Cimetidine given as a single oral dose of 400 mg has been shown to block gastric H2 receptors and to inhibit gastric acid secretions. 23 While it could be argued that this is a local gastric effect, parenteral cimetidine given in sufficient dosage to achieve similar blood levels also results in the suppression of gastric acid secretion. Our dose of 800 mg would therefore have achieved blood levels sufficient to block gastric H2 receptors although it is conceivable that blockade of bronchial receptors was not attained.
An alternative explanation has recently been suggested. 24 The lungs of guinea pigs previously sensitised to ovalbumen were excised after rechallenge and the increase in gas volume was taken as an index of the severity of the reaction. Pre-treatment with burimamide and metiamide significantly increased the severity of the reaction but this effect was not seen with cimetidine. On the other hand, cimetidine, but not burimamide or metiamide, significantly reduced the response to subcutaneous histamine. These findings suggest that cimetidine may differ from other H2 receptor antagonists in having some HI receptor blocking activity. Thus while H2 receptor blockade might enhance mediator release associated HI receptor blockade might prevent the resultant bronchoconstriction. Further support for this view is provided by the finding of an added protective effect when cimetidine is given with an HI receptor antagonist to prevent passive cutaneous anaphylaxis in monkeys. 25 Other workers, however, have failed to demonstrate any significant HI receptor blockade with cimetidine. 26 Cimetidine does not appear to have any significant effect on the bronchial hyperreactivity or ventilatory function of asthmatic patients. Further studies using more specific H2 receptor antagonists in larger doses and by inhalation in spontaneous and induced asthmatic attacks may help clarify the role of HI and H2 receptors in the human bronchus. 
